Literature DB >> 10727432

Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase.

J Deprez1, L Bertrand, D R Alessi, U Krause, L Hue, M H Rider.   

Abstract

A wortmannin-sensitive and insulin-stimulated protein kinase (WISK), which phosphorylates and activates cardiac 6-phosphofructo-2-kinase (PFK-2), was partially purified from perfused rat hearts. Immunoblotting showed that WISK was devoid of protein kinase B (PKB), serum- and glucocorticoid-regulated protein kinase and protein kinase Czeta (PKCzeta). Comparison of the inhibition of WISK, PKCalpha and PKCzeta by different protein kinase inhibitors suggested that WISK was not a member of the PKC family. In addition, WISK contained no detectable phosphoinositide-dependent protein kinase-1 (PDK1) activity. WISK phosphorylated recombinant heart PFK-2 in a time-dependent manner to the extent of 0.4 mol of phosphate incorporated/mol of enzyme subunit, and increased the V(max) of PFK-2 twofold, without affecting the K(m) for fructose 6-phosphate. WISK phosphorylated Ser-466 to a greater extent than Ser-483 in recombinant heart PFK-2, and both sites were demonstrated to be phosphorylated to the same extent by PKB. Gel filtration and in-gel kinase analysis indicated that WISK was a monomer with a M(r) of 56500. Treatment of WISK with protein phosphatase 2A (PP2A) catalytic subunits reversed the effect of insulin, suggesting the involvement of an upstream activating kinase. Indeed, PDK1 was able to partially reactivate the PP2A-treated WISK and this reactivation was not enhanced by PtdIns(3,4,5)P(3)-containing vesicles. Moreover, a single 57000-M(r) band was labelled on incubation of the dephosphorylated WISK preparation with PDK1 and [gamma-(32)P]ATP. These findings provide evidence for the existence of a new protein kinase in the insulin signalling pathway, probably downstream of PDK1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727432      PMCID: PMC1220961     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Purification and characterisation of the insulin-stimulated protein kinase from rabbit skeletal muscle; close similarity to S6 kinase II.

Authors:  A Lavoinne; E Erikson; J L Maller; D J Price; J Avruch; P Cohen
Journal:  Eur J Biochem       Date:  1991-08-01

2.  A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel.

Authors:  I Kameshita; H Fujisawa
Journal:  Anal Biochem       Date:  1989-11-15       Impact factor: 3.365

3.  Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle.

Authors:  P Cohen; S Alemany; B A Hemmings; T J Resink; P Strålfors; H Y Tung
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Catalytic subunit of cAMP-dependent protein kinase.

Authors:  E M Reimann; R A Beham
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Activation of rat heart phosphofructokinase-2 by insulin in vivo.

Authors:  M H Rider; L Hue
Journal:  FEBS Lett       Date:  1984-10-29       Impact factor: 4.124

7.  Evidence for new phosphorylation sites for protein kinase C and cyclic AMP-dependent protein kinase in bovine heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  M H Rider; J van Damme; D Vertommen; A Michel; J Vandekerckhove; L Hue
Journal:  FEBS Lett       Date:  1992-09-28       Impact factor: 4.124

8.  Identification of insulin-stimulated protein kinase-1 as the rabbit equivalent of rskmo-2. Identification of two threonines phosphorylated during activation by mitogen-activated protein kinase.

Authors:  C Sutherland; D G Campbell; P Cohen
Journal:  Eur J Biochem       Date:  1993-03-01

9.  Activation of polysaccharides with 2-iminothiolane and its uses.

Authors:  A C Alagon; T P King
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

10.  Role of fructose 2,6-bisphosphate in the control of heart glycolysis.

Authors:  C Depre; M H Rider; K Veitch; L Hue
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

View more
  5 in total

Review 1.  6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis.

Authors:  Mark H Rider; Luc Bertrand; Didier Vertommen; Paul A Michels; Guy G Rousseau; Louis Hue
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Growth factors can influence cell growth and survival through effects on glucose metabolism.

Authors:  M G Vander Heiden; D R Plas; J C Rathmell; C J Fox; M H Harris; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 3.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Authors:  Sang K Kim; Raymond F Novak
Journal:  Pharmacol Ther       Date:  2006-11-13       Impact factor: 12.310

4.  14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase.

Authors:  Mercedes Pozuelo Rubio; Mark Peggie; Barry H C Wong; Nick Morrice; Carol MacKintosh
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

5.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.

Authors:  Alfonso Mora; Anthony M Davies; Luc Bertrand; Isam Sharif; Grant R Budas; Sofija Jovanović; Véronique Mouton; C Ronald Kahn; John M Lucocq; Gillian A Gray; Aleksandar Jovanović; Dario R Alessi
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.